N Verses Capital, LLC Delcath Systems, Inc. Call Options Transaction History
N Verses Capital, LLC
- $219 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DCTH
# of Institutions
63Shares Held
8.01MCall Options Held
118KPut Options Held
69.9K-
Aigh Capital Management LLC Baltimore, MD2.4MShares$26.5 Million7.28% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.67MShares$18.4 Million2.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA996KShares$11 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA337KShares$3.72 Million0.57% of portfolio
-
Geode Capital Management, LLC Boston, MA245KShares$2.71 Million0.0% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $95.1M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...